RxDoctor Payments Data

Andrew Poole, MD

Adult Reconstructive Orthopaedic Surgery · Knoxville, TNNPI 1568874022

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (47.1%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Stryker at 42.8% of the total. Reporting peaked in 2024 at $10,526 and has fallen 67.9% since, to $3,376 in 2025.

$30,372in general payments, 2019–2025

Across 188 payments — averaging $161.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$13K
  • Smith+Nephew$8K
  • Medical Device Business Services, Inc.$7K
  • Zimmer Biomet$998
  • Johnson & Johnson$679
  • Medacta USA, Inc.$140
  • plus $599 from 13 others

What the payments were for

  • Consulting fees$6,51821%
  • Travel & lodging$14,31547%
  • Food & beverage$9,49131%
  • Education$470%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$30,372 in reported general payments places this provider in the 55th percentile of 27 adult reconstructive orthopaedic surgery providers in Tennessee.

See all adult reconstructive orthopaedic surgery providers in Tennessee

Medicare billing

Part B allowed, 2024
$248,717
Medicare patients
441
Services billed
2,149

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban24$19,350
Celecoxib79$2,207
Naloxone Hcl31$1,930
Oxycodone Hcl308$1,686
Diclofenac Sodium91$1,635
Tizanidine Hcl285$1,520
Meloxicam112$678
Cephalexin202$546
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen39$348
Methylprednisolone26$153
Tramadol Hcl32$150
Ibuprofen12$124
Ondansetron OdtOndansetron14$87
Amoxicillin85$77
Fluconazole11$54

Paid to pharmacies, not to this prescriber.

Other adult reconstructive orthopaedic surgery in Knoxville

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →